Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety of treatment with levocetirizine oral solution in pediatric patients
aged form 6 months to 2 years old with allergic rhinitis or pruritus associated with the skin
diseases.